Finance entity

Freightos

Company CRGO

Freightos is most often covered alongside GeneDx, which appears in 1 of these 2 stories. That works out to roughly 0.1 stories per week across a 174-day span. The clearest coverage concentration is commodities: 1 of 2 stories, with the rest divided among 1 other category.

Last mentioned: 3d ago

Entity pulse

Recent coverage · Freightos

2 stories
5.5 avg impact
0% positive
50% negative

Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 50 percentage points.

  • 50% neutral
  • 50% negative

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Freightos

Freightos is most often covered alongside GeneDx, which appears in 1 of these 2 stories. That works out to roughly 0.1 stories per week across a 174-day span. The clearest coverage concentration is commodities: 1 of 2 stories, with the rest divided among 1 other category. The 5.5 average consequence score is below the beat benchmark of 6.3 in the same window. Each story carries 2.5 original sources on average, compared with 2.7 for the broader beat in this window. Freightos appears in 2 tracked Finance stories published from February 21, 2026 through August 13, 2026.

Stories tracked
2
Per week
0.1
Sources per story
2.5

Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 3957 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Freightos. Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning Freightos 2

Earnings Neutral

Monday Earnings Preview: GeneDx, PepGen, and Freightos in Focus

A trio of high-growth companies across genomics, biotechnology, and digital logistics are set to report quarterly results this Monday. Investors will be closely monitoring GeneDx's path to profitability, PepGen's clinical cash runway, and Freightos's transaction volume growth.

3 sources

Freightos is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.